Clincosm LogoSign in Get a demo

myelofibrosis

Showing 26 - 50 of 170
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelofibrosis; Anemia, Anemia, Myelofibrosis Trial in Canton, Gettysburg (DISC-0974)

Recruiting
  • Myelofibrosis; Anemia
  • +5 more
  • Jacksonville, Florida
  • +6 more
Jan 3, 2023

Multiple Myeloma, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Charlottesville (Pre-biotic foods/drinks)

Completed
  • Multiple Myeloma
  • +11 more
  • Pre-biotic foods/drinks
  • Charlottesville, Virginia
    University of Virginia
Jan 2, 2023

Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Aurora, Seattle (drug, procedure,

Active, not recruiting
  • Acute Biphenotypic Leukemia
  • +18 more
  • Aurora, Colorado
  • +2 more
Dec 28, 2022

Assess Real-World Patient-Reported Outcomes With Fedratinib for

Recruiting
  • Myelofibrosis
    • City, State, Austria
      Local Institution
    Dec 16, 2022

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +11 more
    • Duarte, California
      City of Hope Medical Center
    Dec 8, 2022

    Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Worldwide (parsaclisib, ruxolitinib,

    Recruiting
    • Myelofibrosis
    • +3 more
    • Berkeley, California
    • +176 more
    Dec 1, 2022

    Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Worldwide (parsaclisib, ruxolitinib,

    Recruiting
    • Myelofibrosis
    • +3 more
    • Anchorage, Alaska
    • +172 more
    Dec 1, 2022

    Myelofibrosis Trial in Worldwide (PXS-5505)

    Recruiting
    • Myelofibrosis
    • Birmingham, Alabama
    • +19 more
    Nov 28, 2022

    Myelofibrosis Trial in Hangzhou (Jaktinib Hydrochloride Tablets)

    Recruiting
    • Myelofibrosis
    • Jaktinib Hydrochloride Tablets
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital of Medical School of Zhejiang Univ
    Nov 28, 2022

    Myelofibrosis Trial in Hangzhou (Jaktinib, Placebo to match Hydroxycarbamide, Hydroxycarbamide Tablets)

    Recruiting
    • Myelofibrosis
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital of Medical School of Zhejiang Univ
    Nov 28, 2022

    Myelofibrosis Trial in Worldwide (GB2064)

    Recruiting
    • Myelofibrosis
    • Houston, Texas
    • +11 more
    Nov 23, 2022

    Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Small Lymphocytic Lymphoma Trial in Baltimore (Fludarabine,

    Completed
    Has Results
    • Myelodysplastic Syndrome
    • +13 more
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Nov 2, 2022

    Myelofibrosis Trial in Saint Louis (Fostamatinib, Ruxolitinib)

    Recruiting
    • Myelofibrosis
    • Saint Louis, Missouri
      Washington University School of Medicine
    Oct 26, 2022

    Myelofibrosis Trial in United States (Ruxolitinib)

    Recruiting
    • Myelofibrosis
    • Boston, Massachusetts
    • +4 more
    Oct 21, 2022

    Myelofibrosis, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Tumor Overlap Syndrome Trial in Worldwide

    Recruiting
    • Myelofibrosis
    • +5 more
    • Birmingham, Alabama
    • +27 more
    Oct 17, 2022

    Myelofibrosis Trial (Momelotinib)

    Available
    • Myelofibrosis
    • (no location specified)
    Oct 12, 2022

    Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Worldwide (Pelabresib, Ruxolitinib, Placebo)

    Recruiting
    • Myelofibrosis
    • +3 more
    • Birmingham, Alabama
    • +148 more
    Oct 10, 2022

    Myelofibrosis Trial in Hong Kong (Bomedemstat)

    Recruiting
    • Myelofibrosis
    • Hong Kong, Hong Kong
      Department of Medicine, the University of Hong Kong, Queen Mary
    Oct 3, 2022

    Myelofibrosis Trial in Salt Lake City (Pegylated interferon alpha2a)

    Not yet recruiting
    • Myelofibrosis
    • Pegylated interferon alpha2a
    • Salt Lake City, Utah
      Huntsman Cancer Institute at the University of Utah
    Sep 6, 2022

    Myelofibrosis Trial in Houston (Long-term Follow-up, Quality-of-Life Assessment, Ruxolitinib)

    Active, not recruiting
    • Myelofibrosis
    • Long-term Follow-up
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 7, 2022

    Myelofibrosis, Polycythemia Vera, Thrombocythemia Trial in Worldwide (itacitinib)

    Active, not recruiting
    • Myelofibrosis
    • +2 more
    • New Orleans, Louisiana
    • +20 more
    Aug 25, 2022

    Myelofibrosis Trial in United States (Ruxolitinib, Thalidomide)

    Active, not recruiting
    • Myelofibrosis
    • Middletown, New Jersey
    • +6 more
    Aug 23, 2022

    Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis Trial in Worldwide (ACE-536, Placebo)

    Recruiting
    • Myeloproliferative Disorders
    • +4 more
    • La Jolla, California
    • +184 more
    Aug 22, 2022

    Myelofibrosis Trial in Worldwide (Imetelstat, Best Available Therapy (BAT))

    Recruiting
    • Myelofibrosis
    • La Jolla, California
    • +165 more
    Aug 19, 2022

    Myelofibrosis Trial in Canton (Jaktinib Hydrochloride Tablet)

    Recruiting
    • Myelofibrosis
    • Jaktinib Hydrochloride Tablet
    • Canton, Ohio
      Site 01
    Aug 18, 2022